Acton, MA, United States of America

Vivekananda Pradhan



 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Vivekananda Pradhan

Introduction

Vivekananda Pradhan is an accomplished inventor based in Acton, MA (US). He has made significant contributions to the field of medicine, particularly in the development of treatments involving MAdCAM antagonists. With a total of 2 patents to his name, Pradhan's work is recognized for its potential impact on patient care.

Latest Patents

Pradhan's latest patents focus on dosage regimens for MAdCAM antagonists. The first patent provides a method for treating patients by administering an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Additionally, this invention includes biomarkers for assessing a patient's response to anti-MAdCAM treatment. The second patent mirrors the first, emphasizing the importance of dosage and patient response in treatment protocols.

Career Highlights

Vivekananda Pradhan is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other experts in the field, enhancing the development of innovative treatments.

Collaborations

Some of Pradhan's notable coworkers include Fabio Cataldi and Robert A Clare. Their collaboration has contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Vivekananda Pradhan's contributions to the field of medicine through his patents on MAdCAM antagonists highlight his innovative spirit and dedication to improving patient outcomes. His work at Pfizer Corporation continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…